BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6365657)

  • 41. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC; Buchanan KD; Alam MJ
    Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbohydrate malabsorption following acarbose administration.
    Sobajima H; Mori M; Niwa T; Muramatsu M; Sugimoto Y; Kato K; Naruse S; Kondo T; Hayakawa T
    Diabet Med; 1998 May; 15(5):393-7. PubMed ID: 9609361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Delay of carbohydrate absorption by inhibitors of intestinal alpha-glucosidases.
    Puls W; Krause HP
    Adv Exp Med Biol; 1979; 119():341-6. PubMed ID: 495291
    [No Abstract]   [Full Text] [Related]  

  • 44. α-Glucosidase inhibitory effect of resveratrol and piceatannol.
    Zhang AJ; Rimando AM; Mizuno CS; Mathews ST
    J Nutr Biochem; 2017 Sep; 47():86-93. PubMed ID: 28570943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
    Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
    Walton RJ; Sherif IT; Noy GA; Alberti KG
    Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of acarbose on blood glucose and breath hydrogen after carbohydrate load with sucrose or starch.
    Koytchev R; Richter W; Erkent U; Kirkov V; Dimitrova V; Nern A; Kunter U
    Arzneimittelforschung; 2009; 59(11):557-63. PubMed ID: 20066964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals.
    Seri K; Sanai K; Matsuo N; Kawakubo K; Xue C; Inoue S
    Metabolism; 1996 Nov; 45(11):1368-74. PubMed ID: 8931641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of acarbose on hyperglycemia induced by various carbohydrates in rats and oral starch tolerance in monkeys.
    Ho RS; Aranda CG
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):147-56. PubMed ID: 6847313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
    Gray RS; Olefsky JM
    Metabolism; 1982 Jan; 31(1):88-92. PubMed ID: 7043164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
    Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
    Dig Dis Sci; 1992 Jul; 37(7):1057-64. PubMed ID: 1618053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
    Carswell N; Michaelis OE; Prather ES
    J Nutr; 1989 Mar; 119(3):388-94. PubMed ID: 2646401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol.
    Lembcke B; Diederich M; Fölsch UR; Creutzfeldt W
    Digestion; 1990; 47(1):47-55. PubMed ID: 2292349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat.
    Goda T; Yamada K; Sugiyama M; Moriuchi S; Hosoya N
    J Nutr Sci Vitaminol (Tokyo); 1982 Feb; 28(1):41-56. PubMed ID: 6212654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R; Taylor JA
    Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
    Joubert PH; Venter HL; Foukaridis GN
    Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
    Mörmann JE; Schmid R; Mühlemann HR
    Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.